« Very Recent Iranian-North Korean Nuclear Collusion Revealed | Main | Republicans Have Learned Bupkus From Elections »

November 13, 2006

Anti-Cancer Compound in Green Tea Identified

Topics: Health Issues

Dihydrofolate Reductase plays an important role in human physiology. The blocking of its enzymatic activity is a key element in treatment of many diseases, including cancer and AIDS related infections. PakTribune.com reports today that recently, researchers at the University of Murcia in Spain (UMU) and the John Innes Center (JIC) in Norwich, England have shown that a compound called EGCG (Epigallocatechin gallate) in green tea prevents cancer cells from growing by binding to the enzyme dihydrofolate reductase (DHFR):

[...] "We have shown for the first time that EGCG, which is present in green tea at relatively high concentrations, inhibits the enzyme dihydrofolate reductase (DHFR), which is a recognized, established target for anti-cancer drugs, " says Professor Roger Thorneley, of JIC.

"This is the first time, to our knowledge, a known target for an anti-cancer drug has been identified as being inhibited by EGCG," he added.

Green tea has about five times as much EGCG as regular tea, studies have shown. It decreased rates of certain cancers but scientists were not sure what compounds were involved or how they worked. Nor had they determined how much green tea a person would have to drink to have a beneficial effect, he said.

Thorneley said EGCG is probably just one of a number of anti-cancer mechanisms in green tea.

"We have identified this enzyme in tumour cells that EGCG targets and understand how it stops this enzyme from making DNA. This means we may be able to develop new anti-cancer drugs based on the structure of the EGCG molecule," Thorneley explained.

The scientists decided to look at ECGC after they realized its structure was similar to a cancer drug called methotrexate.

"We discovered that EGCG can kill cancer cells in the same way as methotrexate," Dr Jose Neptuno Rodriguez-Lopez, of UMU, a joint author of the research published in the journal Cancer Research.

EGCG binds strongly to DHFR, which is essential in both healthy and cancerous cells. But it does not bind as tightly as methotrexate, so its side effects on healthy cells could be less severe than those of the drug.

Thorneley said EGCG could be a lead compound for new anti-cancer drugs.

Posted by Richard at November 13, 2006 12:04 PM

Articles Related to Health Issues:

• Compound Found In Plastic Drinking Water Bottles May Alter Gene Expression In Human Breast Cells - Apr 03, 2008
• Green Tea Boosts Antibiotics for Superbugs - Apr 01, 2008
• Lack Of Sleep Can Contribute To Weight Gain - Mar 17, 2008
• Hidden Truth Behind Hotel Drinking Glasses - Dec 08, 2007
• 'Burned foods' double chances of cancer in women - Dec 03, 2007
• Caffeine And Exercise Markedly Decreases Risk Of Skin Cancer - Aug 01, 2007
• Sausage Additive Linked To Cancer - Jul 10, 2007
• High Glucose Levels Can 'Lock' body's Metabolism In A Diabetic State - Jul 05, 2007
• Ten Year Study: Organic Food Double The Level Of Flavonoids - Jul 05, 2007
• L.A. Hospital Employees Receive Training On 'Their Responsibilities' In Death Of Patient (Updated) - Jun 16, 2007